Detalhe da pesquisa
1.
Urinary thiosulfate as failed prostate cancer biomarker - an exemplary multicenter re-evaluation study.
Clin Chem Lab Med
; 53(3): 477-83, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25274944
2.
The presence of prostate cancer at biopsy is predicted by a number of genetic variants.
Int J Cancer
; 134(5): 1139-46, 2014 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24037955
3.
The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.
Prostate
; 73(5): 542-8, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23334858
4.
Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer.
Toxicol Appl Pharmacol
; 268(3): 278-85, 2013 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23466427
5.
Relationship of urinary isoprostanes to prostate cancer occurrence.
Mol Cell Biochem
; 372(1-2): 149-53, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22983829
6.
Thiosulfate in urine as a facilitator in the diagnosis of prostate cancer for patients with prostate-specific antigen less or equal 10 ng/mL.
Clin Chem Lab Med
; 51(9): 1825-31, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23843582
7.
Comparison of the Results of Therapy for cT1 Renal Carcinoma with Nephron-Sparing Surgery (NSS) vs. Percutaneous Thermal Ablation (TA).
J Pers Med
; 12(3)2022 Mar 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35330494
8.
The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men.
Eur J Cancer Prev
; 24(2): 122-7, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25187206
9.
Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance-promising for molecular staging of prostate cancers.
Med Oncol
; 30(1): 391, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23288724
10.
A common nonsense mutation of the BLM gene and prostate cancer risk and survival.
Gene
; 532(2): 173-6, 2013 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24096176
11.
Complication rates after prostate biopsy according to the number of sampled cores.
Cent European J Urol
; 65(3): 116-8, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-24578945
12.
Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population.
Cancer Genet
; 205(9): 432-5, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22824183
13.
Urine markers and prostate cancer.
Cent European J Urol
; 64(1): 9-14, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-24578853